尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Proposed amendments to the Articles of Association
2023-05-10
Next Day Disclosure Return
2023-05-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-05-04
Overseas Regulatory Announcement-Announcement on Obtaining Approval Notice for S
2023-04-25
Announcement Notice of Board Meeting
2023-04-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-04-03
Final Dividend for the Year Ended 31 December 2022
2023-03-29
Overseas regulatory announcement-Announcement on Meloxicam Capsules passing the
2023-03-27
Terms of Reference of the Nomination Committee under the Board of Directors
2023-03-24
Overseas Regulatory Announcement-Announcement on Acetamide Obtaining Notificatio
2023-03-16
<
...
10
11
12
13
14
15
16
...
>
